WTWendy M. Townsend

Wendy M. Townsend

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wendy M. Townsend has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Jean Stiles

    Department of Veterinary Clinical Sciences College of Veterinary Medicine Purdue University West Lafayette IN USA

    6 shared publications
  • George E. Moore

    Department of Comparative Pathobiology Purdue University Indiana USA

    4 shared publications
  • Sheryl G. Krohne

    Department of Small Animal Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907‐2026, USA

    4 shared publications
  • S. Jacobi

    Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA

    2 shared publications
  • Siqi Liang

    Department of Statistics College of Science, Purdue University Indiana USA

    2 shared publications
  • Adam King

    MedVet Chicago Chicago IL USA

    1 shared publication

Latest Publications

  • Clinical Outcomes of Infected Corneal Ulcers in Dogs With or Without the Use of Topical Serum

    by Rachel L. Davis, Emily A. Latham, Wendy M. Townsend

    Objective: To determine if topical serum use impacts clinical outcomes of infected corneal ulcers in dogs. Animals: A total of 252 eyes (237 dogs) undergoing medical and surgical therapy for infected corneal ulcers managed with or without topical serum. Procedures: Patients were identified retrospectively in the same geographic region of the United States. Healing times, visual outcomes, and enucleation were recorded for medically managed ulcers. Visual outcomes and enucleation were recorded for surgically managed ulcers. The number and frequency of topical medications were recorded for all groups. Statistical analyses were performed for all comparisons, with a significance level of p = 0.05. Results: In total, 252 eyes (237 dogs) were included. Of these, 203 eyes underwent medical therapy (150 without serum/53 with serum) and 49 eyes were treated surgically at presentation (35 without serum/14 with serum postoperatively). In the medical group, the use of serum had no impact on healing times ( p = 0.380), visual outcomes ( p = 0.751) or enucleation ( p = 0.433). In the surgery group, visual outcomes ( p = 0.488) and enucleation (no eyes enucleated) were not impacted by serum use. Healing times were not impacted by frequency ( p = 0.092) or number of topical medications ( p = 0.346). Clinical Relevance: To the authors' knowledge, this is the first study to determine if topical serum use affects clinical outcomes of infected corneal ulcers in dogs. Topical serum did not impact healing times, visual outcomes, or enucleation rates of infected corneal ulcers treated medically or surgically in dogs.


  • Open Access

    Microphthalmia with multiple ocular abnormalities in a foal

    by Peter W. Cho, Shin Ae Park, Dodd Sledge, Rachael Gruenwald, Wendy M. Townsend

    Objective: The aim of this report was to provide a clinical description and clinical, ultrasonographic, and histologic images of a foal with microphthalmia and multiple ocular abnormalities.Animals Studied: A 12‐h old Friesian‐American Paint Horse crossbred filly presented for blindness, microphthalmia and marked ventral strabismus in both eyes.Procedure: A complete ophthalmic examination was performed. Ultrasound biomicroscopy and B‐mode ultrasonography were performed. The globes were submitted for histopathology.Results: Ultrasound biomicroscopy demonstrated a hyperechoic cornea void of the typical epithelium, stroma, and Descemet's membrane layers. The anterior chamber was spanned by thick strands of hyperechoic tissue extending from the iris to the cornea. The lens was not visualized. B‐mode ultrasound showed aphakia and mild, mottled echogenicity within the vitreous with no evidence of retinal detachment. On histopathology, both globes were microphthalmic with poorly defined corneal tissue. The anterior chambers were poorly formed and contained lacrimal glandular tissue. Portions of iridal tissue were present, but no lenses were noted. The retinas were segmentally detached and markedly atrophied with areas of retina dysplasia noted.Conclusions: This report provides a clinical, ultrasonographic and histologic description of a rare, congenital condition in a foal characterized by microphthalmia, aphakia, poorly defined corneal tissue, choristomatous differentiation of the anterior segment and retinal dysplasia.


  • Open Access

    Endoscopic‐guided diagnosis of and interventional stent placement for nasolacrimal duct obstruction in a horse

    by Levi H. Smith, Larry Adams, Maxime Derré, Wendy M. Townsend

    ObjectiveTo describe the successful use of endoscopy to visualize and place a soft canine ureteral stent to relieve a chronic nasolacrimal duct (NLD) obstruction in a horse. Animal StudiedA 7-year-old, Quarter horse gelding. ProcedureUnder general anesthesia, retrograde nasolacrimal endoscopy was performed using an 8.5 Fr Storz Flex XC ureteroscope through the nasal punctum (NP). An obstructive web of fibrous tissue was visualized approximately 20 cm proximal to the NP. A 0.035 ''/150 cm hydrophilic guidewire was passed normograde from the ventral lacrimal punctum and used to puncture the stenotic tissue. Then, a 5.0Fr/70 cm open-end ureteral catheter was threaded normograde over the guidewire and NLD patency was re-established. The catheter confirmed a NLD length of 30 cm and was then removed. A 5.0Fr/22-32 cm Universa (c) Soft Ureteral Stent was threaded normograde over the guidewire until the loops of the stent were exposed at each end. The guidewire was removed and the stent loops were sutured in place. ResultsThe stent was withdrawn 1 month after the procedure. Telephone follow-up with the client reported significant improvement in the amount of ocular discharge and decreased sensitivity around the face and ears. ConclusionEndoscopy is a safe and effective procedure allowing for definitive diagnosis of NLD obstruction and to assist in interventional procedures. Placement of a canine indwelling ureteral stent seems to be an effective alternative treatment option for equine NLD obstruction compared to conventional invasive surgical procedures.


  • Evaluation of equine corneal disease using ultrasound biomicroscopy

    by Alessandra V. Keenan, Wendy M. Townsend

    Objective To describe the clinical use of ultrasound biomicroscopy (UBM) to evaluate equine corneal disease. Methods Images were obtained using a 50‐MHz probe ultrasound biomicroscopy system (Quantel Aviso) and Clear Scan® probe cover. Six horses with corneal disease were evaluated via UBM for lesion size, lesion depth, and continuity of Descemet's membrane. Horses were sedated and received auriculopalpebral nerve blocks and application of topical anesthetic prior to UBM. Results Ultrasound biomicroscopy was easily performed in all cases. UBM evaluation of three cases of corneo‐limbal squamous cell carcinoma yielded information regarding lesion depth for planning of keratectomies using fixed‐depth keratomes and subsequent β‐radiation therapy. Corneal depth and continuity of Descemet's membrane were determined in two horses with stromal abscesses and allowed for planning of therapeutic options. In one horse with a corneal foreign body, UBM contributed to accurate assessment of the foreign body's stromal depth, which could not be assessed during ophthalmic examination due to extensive corneal cellular infiltrate. The information regarding corneal depth allowed for more accurate pre‐surgical planning in patients with opaque corneal lesions. Conclusions Ultrasound biomicroscopy was easily performed and provided useful information regarding lesion depth and continuity of Descemet's membrane for patients with corneo‐limbal squamous cell carcinoma, stromal abscesses, and a corneal foreign body, allowing for increased precision in pre‐surgical planning and development of therapeutic protocols.


  • Double drape tectonic patch with cyanoacrylate glue for surgical repair of corneal defects: 8 cases

    by Elena N. Rodriguez, Wendy M. Townsend, Jean Stiles

    Objective: To describe the use of a double drape tectonic patch with cyanoacrylate glue technique for the treatment of deep or penetrating corneal defects in cats and dogs.Animals studied: Eight client‐owned animals of which five were cats and three were dogs.Procedure: Eight cases: Four with descemetoceles, three with corneal perforations, and one with a deep stromal ulcer were treated with a double layer of plastic drape material adhered to the cornea with a cyanoacrylate (2‐octyl or 2‐octyl, N‐butyl)‐based tissue adhesive. The patch was then covered with a third eyelid flap.Results: Seven of the eight eyes healed uneventfully with a median time to healing time of 20 days (range 14–28 days). After healing, the glue patch had loosened and was removed. One eye of one cat developed bacterial keratitis with an iris prolapse adjacent to the patch and was subsequently enucleated. Only two of the eight eyes had increased corneal neovascularization.Conclusion: Treatment of deep or penetrating corneal defects with a double drape tectonic patch and cyanoacrylate glue is a viable option which may be a faster and less expensive alternative to other globe sparing surgical options.


  • Commercial amniotic membrane extract for treatment of corneal ulcers in adult horses

    by Victoria N. Lyons, Wendy M. Townsend, George E. Moore, Siqi Liang

    Background Amniotic membrane extract enhances the rate of epithelialisation after corneal ulceration in several species but has not been studied in the equine cornea. Objectives To evaluate the effect of amniotic membrane extract on re‐epithelialisation of equine corneal ulcers compared with ulcers treated with antibiotic, antifungal and mydriatic medical therapy alone, and to evaluate equine corneal healing after experimentally induced superficial ulceration. Study design Masked, randomised, controlled experimental trial. Methods Superficial, 8 mm corneal ulcers were created bilaterally in each horse. One eye was treated with amniotic membrane extract and the opposite was control. Both eyes were treated with medical therapy. Treatment eyes received amniotic membrane extract, and control eyes received the amniotic membrane extract vehicle. Ulcers were stained with fluorescein and photographed in 12‐hour increments until completely healed. Ulcer surface area was determined by analysing photographs with ImageJ. A mixed linear model was used to compare ulcer surface area and hours until healing between treatment groups. A regression model was also used to calculate corneal re‐epithelialisation rate over time. Results Regardless of therapy, healing occurred in two phases: an initial rapid phase of 0.88 mm2/hr (95% CI: 0.81‐0.94 mm2/hr) for approximately 48‐54 hours followed by a second, slow phase of 0.07 mm2/hr (95% CI: 0.04‐0.09 mm2/hr). Most eyes healed within 135.5 ± 48.5 hours. Treatment (amniotic membrane extract vs. control) was not significantly associated with size of ulcers over time (P = .984). Discomfort was minimal to absent in all horses. Main limitations Results achieved experimental studies may differ from outcomes in the clinical setting. Conclusions There was no significant difference in healing rate with addition of amniotic membrane extract to medical therapy for equine superficial corneal ulcers. A biphasic corneal healing process was observed, with an initial rapid phase followed by a slow phase. Further study will be needed to determine whether amniotic membrane extract will be helpful for infected or malacic equine corneal ulcers.


  • Open Access

    Golden retriever pigmentary uveitis: Vision loss, risk factors for glaucoma, and effect of treatment on disease progression

    by Haley E. Jost, Wendy M. Townsend, George E. Moore, Siqi Liang

    Objective In previous reports, almost half of Golden Retrievers with Pigmentary Uveitis (GRPU) have lost vision in an eye within a year of diagnosis. The purpose of this study was to determine the proportion of GRPU affected dogs with vision loss, risk factors for the development of glaucoma, and effect of treatment on disease progression. Animals Studied Client owned Golden Retrievers. Procedures Two complete ophthalmic examinations were performed at least 6 months apart. Visual status, presence of glaucoma, GRPU score, and treatment were recorded. A proportional odds (ordinal logistic) model was fitted to determine whether the use of topical steroidal or non-steroidal (NSAID) ophthalmic preparations was associated with a change in GRPU scores. Results Twenty-nine Golden Retrievers, 58 eyes, were included. One eye was enucleated after the first examination. On first examination, 57/58 (98.3%) eyes and 29/29 (100%) dogs were visual. At the second examination, 48/57 (84.2%) eyes and 25/29 (86.2%) dogs were visual. Vision loss in 7/9 (77.8%) eyes was secondary to glaucoma. Posterior synechia and fibrinous material in the anterior chamber were significant risk factors for the development of glaucoma (P < .001). There was no significant difference in the change in GRPU score between eyes receiving topical steroids and topical NSAIDs (P = .14). Time between examinations was a significant factor in disease progression (increased GRPU score; P = .016). Conclusion The number of eyes and dogs that retained vision was higher than previous reports. No topical treatment was superior in slowing disease progression. Golden Retriever Pigmentary Uveitis is a slowly progressive disease.


  • Open Access

    Golden retriever pigmentary uveitis: Challenges of diagnosis and treatment

    by Wendy M. Townsend, Jane A. Huey, Emily McCool, Adam King, Kathryn A. Diehl

    Pigmentary uveitis (PU), also known as Golden Retriever Pigmentary Uveitis (GRPU), is a common ocular condition of Golden Retrievers that has severe, vision‐threatening ocular complications and can require surgical intervention. In order to ensure consistency in the diagnosis of GRPU between examiners, a specified set of diagnostic criteria must be applied. This is critical to ensure owners, breeders, and veterinary ophthalmologists maintain confidence in the ocular certification process. Therefore, current and former members of the American College of Veterinary Ophthalmologists’ Genetics Committee came together to draft this Viewpoint Article on the challenges of diagnosis and treatment of Golden Retriever Pigmentary Uveitis for veterinary ophthalmologists, Golden Retriever owners, and Golden Retriever breeders.


  • Open Access

    Antibacterial activity and safety of commercial veterinary cationic steroid antibiotics and neutral superoxidized water

    by Benjamin E Bergstrom, Ahmed Abdelkhalek, Waleed Younis, G Kenitra Hammac, Wendy M Townsend, Mohamed N Seleem

    Antibiotic resistance of bacteria common to the ocular surface is an evolving problem. Thus, novel treatment options with new modes of action are required. We investigated the antibacterial activity and safety of three commercially available topical veterinary ophthalmic products (cationic steroid antibiotics, products A and B, and a neutral superoxidized water, product C) to determine their potential use as antimicrobial alternatives. The minimum inhibitory concentrations (MIC) of the three products were determined against 17 antibiotic resistant bacterial clinical isolates from the ocular surface. Using a standard cytotoxicity assay, the products at varying concentrations were evaluated with a corneal fibroblast cell line and a macrophage-like cell line to determine their potential toxic effect in vitro. The commercial ophthalmic solutions, ofloxacin 0.3%, tobramycin 0.3% and gentamicin 0.3% were used as positive controls for the MIC and tobramycin 0.3% was used as positive control for the cytotoxicity assays. For the MIC, Product C showed no inhibition of growth for any organisms, while Products A and B showed inhibition of growth similar to slightly less than the positive controls. For the cytotoxicity assays, Product C exhibited minimal toxicity while Products A and B exhibited toxicity similar to the controls. In conclusion, Product C had no antibacterial activity in these assays, while Products A and B had antibacterial profiles similar to slightly less than common topical ophthalmic antibiotics and cytotoxicity profiles similar to common topical ophthalmic antibiotics. To our knowledge, this is the first report on the antibacterial activity and safety of the cationic steroid antibiotics and superoxidized water.